| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/09/1998 | WO1998014565A1 Novel receptor that causes cell death |
| 04/09/1998 | WO1998014564A1 Synthetic hpv16 virus-like particles |
| 04/09/1998 | WO1998014563A1 spsA POLYNUCLEOTIDES AND POLYPEPTIDES |
| 04/09/1998 | WO1998014480A1 G protein-coupled receptor antagonists |
| 04/09/1998 | WO1998014479A1 Method of searching for physiologically active substances and process for producing the same |
| 04/09/1998 | WO1998014478A1 Continuous low-dose administration of parathyroid hormone or its agonist |
| 04/09/1998 | WO1998014477A1 THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING DISEASE STATES WITH LEUKOCYTE ADHESION INHIBITOR-1 (LAI-1), AND CHEMOKINE BETA-11 (Ckβ-11) |
| 04/09/1998 | WO1998014476A1 Pharmaceutical compositions containing an mpl ligand |
| 04/09/1998 | WO1998014475A1 Vertebrate smoothened proteins |
| 04/09/1998 | WO1998014474A1 E2f activity inhibitory compounds |
| 04/09/1998 | WO1998014473A1 Colostrinin, and uses thereof |
| 04/09/1998 | WO1998014472A1 Pfs28 fusion proteins |
| 04/09/1998 | WO1998014471A1 Calcium-integrin binding protein |
| 04/09/1998 | WO1998014470A2 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | WO1998014469A2 An epithelial protein and dna thereof for use in early cancer detection |
| 04/09/1998 | WO1998014467A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | WO1998014466A1 Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 04/09/1998 | WO1998014464A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 04/09/1998 | WO1998014463A1 MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC TO THE MOLECULE, AND USES THEREOF |
| 04/09/1998 | WO1998014462A1 cDNA FOR FANCONI ANEMIA COMPLEMENTATION GROUP A |
| 04/09/1998 | WO1998014461A1 NOVEL spsB |
| 04/09/1998 | WO1998014220A2 TECHNETIUM-99m LABELED CHELATOR INCORPORATED CYCLIC PEPTIDES |
| 04/09/1998 | WO1998014210A1 Method for treating allergic lung disease |
| 04/09/1998 | WO1998014206A1 T cells mediating an immune response and methods of use |
| 04/09/1998 | WO1998014203A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | WO1998014201A1 Method for treatment of immunodeficiency virus infection |
| 04/09/1998 | WO1998014071A1 Process for isolating glycomacropeptide from dairy products with a phenylalanine impurity of 0.5 %w/w |
| 04/09/1998 | WO1998006435A3 COMPOSITIONS OF ANTICHLAMYDIAL AGENTS FOR THE DIAGNOSIS AND MANAGEMENT OF INFECTION CAUSED BY $i(CHLAMYDIA) |
| 04/09/1998 | WO1998004710A3 Live recombinant bhv/brsv vaccine |
| 04/09/1998 | WO1998002547A3 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications |
| 04/09/1998 | WO1998001557A3 Mammalian chemokine reagents |
| 04/09/1998 | WO1998001549A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 04/09/1998 | WO1998001474A3 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth |
| 04/09/1998 | WO1998000546A3 Bacillus thuringiensis toxins active against noctuidae pests |
| 04/09/1998 | WO1997048804A3 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 04/09/1998 | WO1997045746A3 Prion protein binding proteins and uses thereof |
| 04/09/1998 | WO1997045550A3 Mini-adenoviral vector |
| 04/09/1998 | WO1997039721A3 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 04/09/1998 | DE19640733A1 Polypeptide than binds to CD30 without cell activation |
| 04/09/1998 | DE19637518A1 PTX-sensitive G-Proteine, ihre Herstellung und Verwendung PTX-sensitive G-proteins, their production and use |
| 04/09/1998 | CA2647169A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2645721A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2574049A1 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 04/09/1998 | CA2269079A1 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 04/09/1998 | CA2268013A1 Compositions and methods for the prevention and diagnosis of human granulocytic ehrlichiosis |
| 04/09/1998 | CA2267683A1 Method for treatment of immunodeficiency virus infection |
| 04/09/1998 | CA2267675A1 Method for treating allergic lung disease |
| 04/09/1998 | CA2267664A1 Human telomerase reverse transcriptase |
| 04/09/1998 | CA2267645A1 A polynucleotide herpes virus vaccine |
| 04/09/1998 | CA2267641A1 Method of purifying protein from inclusion bodies |
| 04/09/1998 | CA2267467A1 Technetium-99m labeled chelator incorporated cyclic peptides that bind to the gpiib/iiia receptor as imaging agents |
| 04/09/1998 | CA2267202A1 Mage-10 encoding cdna, the tumor rejection antigen precursor mage-10, antibodies specific to the molecule, and uses thereof |
| 04/09/1998 | CA2267193A1 Therapeutic compositions and methods for treating disease states with myeloid progenitor inhibitory factor-1 (mpif-1), monocyte colony inhibitory factor (m-cif), and macrophage inhibitory factor-4 (mip-4) |
| 04/09/1998 | CA2267190A1 G protein-coupled receptor antagonists |
| 04/09/1998 | CA2267188A1 E2f activity inhibiting compound |
| 04/09/1998 | CA2267181A1 Vertebrate smoothened proteins |
| 04/09/1998 | CA2267131A1 Therapeutic compositions and methods for treating disease states with leukocyte adhesion inhibitor-1 (lai-1), and chemokine beta-11 (ck.beta.-11) |
| 04/09/1998 | CA2267121A1 Secreted proteins and polynucleotides encoding them |
| 04/09/1998 | CA2267097A1 Human growth gene and short stature gene region |
| 04/09/1998 | CA2267092A1 Mammalian chemokines |
| 04/09/1998 | CA2267063A1 A method and compositions for treatment of insulin-dependant diabetes mellitus |
| 04/09/1998 | CA2266752A1 Telomerase reverse transcriptase |
| 04/09/1998 | CA2266413A1 Elongin a and c functional domains |
| 04/09/1998 | CA2266327A1 Novel receptor that causes cell death |
| 04/09/1998 | CA2265466A1 Human sulfonylurea receptor surh |
| 04/09/1998 | CA2265447A1 Novel human phospholemman-like protein |
| 04/09/1998 | CA2242590A1 T cells mediating an immune response and methods of use |
| 04/08/1998 | EP0834572A2 Alpha, gamma-diaminobutyric acid (DAB) containing oligopeptide derivatives |
| 04/08/1998 | EP0834568A2 Novel saliva binding protein |
| 04/08/1998 | EP0834567A2 Compounds and methods for the diagnosis and treatment of Babesia microti infection |
| 04/08/1998 | EP0834566A2 Cotton plant gene |
| 04/08/1998 | EP0834565A2 A G-protein coupled receptor HUVCT36 |
| 04/08/1998 | EP0834564A2 A mouse genomic clone of the CC-CKR5 receptor |
| 04/08/1998 | EP0834563A2 Human 7-transmembrane receptor, member of the chemokine receptor family, named Strl-33 |
| 04/08/1998 | EP0834562A1 Polypetide exhibiting calpain inhibition activity and method for the preparation thereof |
| 04/08/1998 | EP0834561A1 A gene related to migraine in man |
| 04/08/1998 | EP0834560A1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof |
| 04/08/1998 | EP0834556A1 Methods for culturing cells |
| 04/08/1998 | EP0834076A1 Process for determining auto-antibodies against anti-tsh-receptor auto-antibodies |
| 04/08/1998 | EP0833948A1 Colon specific gene and protein |
| 04/08/1998 | EP0833947A1 Variant presenilin-2 genes |
| 04/08/1998 | EP0833943A1 Method for identifying secretory genes in helicobacter pylori |
| 04/08/1998 | EP0833941A1 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 04/08/1998 | EP0833935A1 Cell line producing analgesic compounds for treating pain |
| 04/08/1998 | EP0833933A1 A method for producing influenza hemagglutinin multivalent vaccines |
| 04/08/1998 | EP0833932A2 Use of ovary-tissue transcriptional factors |
| 04/08/1998 | EP0833930A2 Fused soluble mhc heterodimer:peptide complexes and their uses |
| 04/08/1998 | EP0833929A1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 04/08/1998 | EP0833928A1 Novel beta-xylosidase, nucleotide sequence encoding it, and use thereof |
| 04/08/1998 | EP0833925A1 Diagnostic test for equine arteritis virus mediated disease |
| 04/08/1998 | EP0833924A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 04/08/1998 | EP0833922A1 A novel method to isolate mutants and to clone the complementing gene |
| 04/08/1998 | EP0833921A1 ADHERENCE GENE FROM $i(HELICOBACTER PYLORI) AND POLYPEPTIDE CODED THEREBY |
| 04/08/1998 | EP0833920A2 Transferrin receptor genes |
| 04/08/1998 | EP0833919A1 Type f botulinum toxin and use thereof |
| 04/08/1998 | EP0833918A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |
| 04/08/1998 | EP0833917A2 Malarial pre-erythrocytic stage polypeptide molecules |
| 04/08/1998 | EP0833916A1 Decorin binding protein compositions and methods of use |
| 04/08/1998 | EP0833915A1 Plant regulatory proteins iii |
| 04/08/1998 | EP0833914A1 Human chemokine beta-11 and human chemokine alpha-1 |